Research on prostate cancer cells (22Rv1 and PC-3) showed that the anti-tumor mechanisms of OBZ increased the expression of two well-known tumor suppressors, microRNA (miRNA)-204 and p53 [31]. This evidence concerns the gene TP53 and neoplasm.